Marketing-authorisation holder · Canada
Juno Pharmaceuticals Corp.
31 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · Canada
31 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 31
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| BIVALIRUDIN FOR INJECTION250 mg / vial · Powder For Solution | Bivalirudin | Canada | Marketed | 2023 |
| BORTEZOMIB FOR INJECTION3.5 mg / vial · Powder For Solution | Bortezomib | Canada | Marketed | 2023 |
| FOSAPREPITANT FOR INJECTION150 mg / vial · Powder For Solution | Aprepitant | Canada | Marketed | 2025 |
| IMDUR60 mg · Tablet (Extended-Release) | Isosorbide mononitrate | Canada | Not marketed | 1994 |
| MICAFUNGIN SODIUM FOR INJECTION50 mg / vial · Powder For Solution | Micafungin | Canada | Marketed | 2023 |
| MICAFUNGIN SODIUM FOR INJECTION100 mg / vial · Powder For Solution | Micafungin | Canada | Marketed | 2023 |
| NOREPINEPHRINE BITARTRATE INJECTION1 mg / ml · Solution | Norepinephrine | Canada | Marketed | 2024 |
| 0.9% SODIUM CHLORIDE INJECTION, USP9 mg / ml · Solution | Sodium chloride | Canada | Cancelled | |
| AMIKACIN SULFATE INJECTION250 mg / ml · Solution | Amikacin | Canada | Cancelled | |
| BORTEZOMIB FOR INJECTION2.5 mg / vial · Powder For Solution | Bortezomib | Canada | Cancelled | 2020 |
| BORTEZOMIB FOR INJECTION1 mg / vial · Powder For Solution | Bortezomib | Canada | Cancelled | |
| DAPTOMYCIN FOR INJECTION500 mg / vial · Powder For Solution | Daptomycin | Canada | Cancelled | |
| DEXAMETHASONE10 mg / ml · Solution | Dexamethasone | Canada | Cancelled | |
| DEXAMETHASONE4 mg / ml · Solution | Dexamethasone | Canada | Cancelled | |
| DEXAMETHASONE UNIDOSE10 mg / ml · Solution | Dexamethasone | Canada | Cancelled | |
| DIPHENHYDRAMINE HYDROCHLORIDE INJECTION, USP50 mg / ml · Solution | Diphenhydramine | Canada | Cancelled | |
| GEMCITABINE INJECTION38 mg / ml · Solution | Gemcitabine | Canada | Cancelled | |
| GLYCOPYRROLATE INJECTION0.2 mg / ml · Solution | Glycopyrronium | Canada | Cancelled | |
| GLYCOPYRROLATE INJECTION MULTIDOSE0.2 mg / ml · Solution | Glycopyrronium | Canada | Cancelled | |
| HALOPERIDOL INJECTION5 mg / ml · Solution | Haloperidol | Canada | Cancelled | |
| ICATIBANT INJECTION10 mg / ml · Solution | Icatibant | Canada | Cancelled | |
| LABETALOL HYDROCHLORIDE INJECTION5 mg / ml · Solution | Labetalol | Canada | Cancelled | |
| MELPHALAN FOR INJECTION50 mg / vial · Kit, Powder For Solution | Melphalan | Canada | Cancelled | |
| NEOSTIGMINE METHYLSULFATE INJECTION, USP1 mg / ml · Solution | Neostigmine | Canada | Cancelled | |
| NEOSTIGMINE METHYLSULFATE INJECTION, USP0.5 mg / ml · Solution | Neostigmine | Canada | Cancelled |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 31 | 7 | 24 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Report an error or request removalCorrections from the company itself are welcome.
Ranked by their number of medicines.